Risk-Adapted Approach to clinical trials and Risk Assessments
Information
Type
Guidance
Regulated products
Medical Devices
Topics
Health And Social Care
Published
January 28, 2022
Last updated
January 28, 2022
Description
The MHRA have implemented a dual strategy for a risk-adapted approach to clinical trials in the UK.
Tags
Organization
Country / Region
United Kingdom
License
Open Government Licence 2.0 (United Kingdom)